Clinical Trial

Cohort of Tumors With POLE/D1 Mutation

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 8, 2024 (before its estimated October 6, 2025 completion). Its status may not reflect the trial's current state.
Summary
Primary objective of this study is to identify and describe the clinico-biological and molecular characteristics of tumors with somatic POLE (Polymerase ɛ)/POLD1 mutation identified by molecular biology platforms for all stages and primary sites combined
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05103969
Lead Sponsor Federation Francophone de Cancerologie Digestive
Conditions Tumors, POLE Exonuclease Domain Mutation, POLD1 Gene Mutation
Enrollment 100 participants
Start Date 2021-10-05
Primary Completion 2025-10-06 (estimated)
Study Completion 2025-10-06 (estimated)
Updated on ClinicalTrials.gov 2024-07-08